sr141716 has been researched along with AKB48 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bush, JM; Cabanlong, CV; Fantegrossi, WE; Fujiwara, R; Fukuda, S; Gogoi, J; Jackson, BK; McCain, K; Pinson, A; Prather, PL; Radominska-Pandya, A; Shoeib, A; Yarbrough, AL | 1 |
1 other study(ies) available for sr141716 and AKB48
Article | Year |
---|---|
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.
Topics: Adamantane; Animals; Cannabinoid Receptor Antagonists; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Humans; Indazoles; Male; Mice; Mice, Inbred C57BL; Microsomes, Liver; Oxidation-Reduction; Polymorphism, Genetic; Protein Binding; Receptor, Cannabinoid, CB1; Recombinant Proteins; Rimonabant; Sex Factors | 2020 |